Monday, 26 July 2010

Vitagel




Vitagel may be available in the countries listed below.


Ingredient matches for Vitagel



Retinol

Retinol palmitate (a derivative of Retinol) is reported as an ingredient of Vitagel in the following countries:


  • Germany

International Drug Name Search

Sunday, 25 July 2010

Oxaliplatin




In the US, Oxaliplatin (oxaliplatin systemic) is a member of the drug class alkylating agents and is used to treat Colorectal Cancer.

US matches:

  • Oxaliplatin

  • Oxaliplatin Intravenous

UK matches:

  • Oxaliplatin 5mg/ml powder for solution for infusion (Actavis UK Ltd)
  • Oxaliplatin 5mg/ml powder for solution for infusion (SPC)
  • Oxaliplatin Hospira 5 mg/ml Concentrate for Solution for Infusion (SPC)
  • Oxaliplatin Hospira 5 mg/ml Powder for Solution for Infusion (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XA03

CAS registry number (Chemical Abstracts Service)

0061825-94-3

Chemical Formula

C8-H14-N2-O4-Pt

Molecular Weight

397

Therapeutic Category

Antineoplastic agent

Chemical Names

[(1R,2R)-1,2-Cyclohexanediamine-N,N'][oxalato(2-)-O,O']platinum (WHO)

Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(1R-trans))-

Foreign Names

  • Oxaliplatinum (Latin)
  • Oxaliplatin (German)
  • Oxaliplatine (French)
  • Oxaliplatino (Spanish)

Generic Names

  • Oxaliplatin (OS: BAN, USAN)
  • Oxaliplatine (OS: DCF)
  • 1670 RB (IS)
  • 1-OHP (IS)
  • Debiopharm (IS: NipponKayaku)
  • JM 83 (IS)
  • L-OHP (IS: NipponShinyaku)
  • NSC 266046 (IS)
  • RP 54780 (IS)
  • SR 96669 (IS)
  • Oxaliplatin (PH: BP 2010, Ph. Eur. 6)
  • Oxaliplatinum (PH: Ph. Eur. 6)

Brand Names

  • Axioplatin
    Apocare, Germany


  • Bendaplatin
    Bendalis, Germany


  • Crisapla
    LKM, Argentina


  • Croloxat
    Cell pharm, Germany


  • Dabenzol
    Filaxis, Argentina


  • Dacotin
    Dr. Reddys, India


  • Dacplat
    Pfizer, Argentina


  • Ebeoxal
    Ebewe Pharma, Slovakia


  • Elotaxin
    Sanofi-Aventis, Latvia


  • Eloxatin
    Aventis, Bulgaria; Chinoin, Bulgaria; Euro, Netherlands; Glaxo Wellcome, Bulgaria; Sanofi Aventis, Antigua & Barbuda; Sanofi Aventis, Netherlands Antilles; Sanofi Aventis, Barbados; Sanofi Aventis, Bermuda; Sanofi Aventis, Bahamas; Sanofi Aventis, Guyana; Sanofi Aventis, Haiti; Sanofi Aventis, Jamaica; Sanofi Aventis, Cayman Islands; Sanofi Aventis, Saint Lucia; Sanofi Aventis, Trinidad & Tobago; Sanofi Aventis, Saint Vincent & The Grenadines; Sanofi Winthrop, Bulgaria; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Bahrain; Sanofi-Aventis, Brazil; Sanofi-Aventis, Canada; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Germany; Sanofi-Aventis, Denmark; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Estonia; Sanofi-Aventis, Egypt; Sanofi-Aventis, Finland; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Greece; Sanofi-Aventis, Guatemala; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Honduras; Sanofi-Aventis, Croatia (Hrvatska); Sanofi-Aventis, Hungary; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Israel; Sanofi-Aventis, Iraq; Sanofi-Aventis, Iran; Sanofi-Aventis, Italy; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Malta; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Oman; Sanofi-Aventis, Panama; Sanofi-Aventis, Peru; Sanofi-Aventis, Poland; Sanofi-Aventis, Qatar; Sanofi-Aventis, Romania; Sanofi-Aventis, Serbia; Sanofi-Aventis, Saudi Arabia; Sanofi-Aventis, Sweden; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovenia; Sanofi-Aventis, Slovakia; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Syria; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis, United States; Sanofi-Aventis, Venezuela; Sanofi-Aventis, Vietnam; Sanofi-Aventis, Yemen; Sanofi-Aventis, South Africa; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Aventis S.A.U., Spain; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Jordan; Sanofi-Synthelabo, Luxembourg; Thissen, Bulgaria


  • Eloxatine
    Sanofi Aventis, Tunisia; Sanofi-Aventis, France; Sanofi-Aventis, Georgia; Sanofi-Aventis, Russian Federation


  • Elplat
    Yakult, Japan


  • Euroxaliplatin
    Lapharm, Germany


  • Glenoxal
    Glenmark, India


  • Kebir
    Aspen, Argentina


  • Medoxa
    Medac, Germany


  • Metaplatin
    Teva, Argentina


  • Mitog
    Microsules, Argentina


  • Oksaliplatin Ebewe
    Ebewe, Estonia; Ebewe, Lithuania


  • Oksaliplatin Medac
    medac, Estonia; medac, Lithuania


  • Oksaliplatin Merck
    Merck, Slovenia


  • Oksaliplatin Pliva
    Pliva, Slovenia


  • Oksaliplatin Teva
    Teva, Slovenia


  • Oloxayne
    Mayne, Estonia


  • Oplat
    Tecnofarma, Colombia


  • O-Plat
    Raffo, Argentina; Tecnofarma, Chile; Zodiac, Brazil


  • Otaplat
    UKR, Slovakia


  • Oxalatin
    Spirit Pharmaceuticals, Australia


  • Oxalip
    TTY Biopharm, Taiwan


  • Oxaliplan
    Cancernova, Germany


  • Oxaliplatin Arcana
    Arcana, Austria


  • Oxaliplatin Ebewe
    Ebewe, Austria; Ebewe, Hungary; Ebewe, Malta; Ebewe, Netherlands; Ebewe, Tunisia; Ebewe Pharma, Denmark; Meda, Sweden; Würth, Croatia (Hrvatska)


  • Oxaliplatin Gerolymatos
    png Gerolymatos, Greece


  • Oxaliplatin Hexal
    Hexal, Germany


  • Oxaliplatin Hosipra
    Hospira, Austria; Hospira, Belgium; Hospira, Germany; Hospira, Hungary; Hospira, Ireland; Hospira Nordic, Sweden


  • Oxaliplatin Hospira
    Hospira, Greece


  • Oxaliplatin Kabi
    Fresenius, Germany


  • Oxaliplatin Mayne
    Hospira, Luxembourg; Mayne, Denmark; Mayne, Estonia; Mayne, Ireland; Mayne, Lithuania; Mayne, Latvia


  • Oxaliplatin medac
    Medac, Austria; Medac, Finland; Medac, Greece; Medac, Hungary; Medac, Sweden


  • Oxaliplatin NC
    NeoCorp, Germany


  • Oxaliplatin onkovis
    Onkovis, Germany


  • Oxaliplatin Pliva
    Pliva, Bosnia & Herzegowina; Pliva, Czech Republic; Pliva, Croatia (Hrvatska); Pliva, Latvia


  • Oxaliplatin Sandoz
    Sandoz, Germany; Sandoz, Lithuania; Sandoz, Latvia


  • Oxaliplatin STADA
    Stada, Austria


  • Oxaliplatin Teva
    Pharmachemie, Latvia; Providens, Croatia (Hrvatska); Teva, Austria; Teva, Greece; Teva, Sweden


  • Oxaliplatin Vianex
    NordMedica, Sweden


  • Oxaliplatin Winthrop
    Sanofi-aventis, Czech Republic; Sanofi-aventis, Sweden; Sanofi-aventis, Slovenia; Winthrop, Germany; Winthrop, Denmark


  • Oxaliplatin
    Actavis, Malta; Ebewe, United States; Fresenius Kabi Oncology, United States; Hospira, Australia; Hospira, United States; Sun, United States; Teva, Norway; Teva USA, United States


  • Oxaliplatina Actavis
    Actavis, Slovakia


  • Oxaliplatina Winthrop
    Winthrop, Portugal


  • Oxaliplatin-Actavis
    Actavis, Austria; Actavis, Germany


  • Oxaliplatina-Teva
    Teva, Slovakia


  • Oxaliplatine Actavis
    Actavis, France


  • Oxaliplatine CF
    Centrafarm, Netherlands


  • Oxaliplatine Dakota Pharm
    Sanofi-Aventis, France


  • Oxaliplatine Ebewe
    Ebewe, France


  • Oxaliplatine EG
    Eurogenerics, Belgium


  • Oxaliplatine Fresenius
    Fresenius, Netherlands


  • Oxaliplatine Generics
    Generics, Greece


  • Oxaliplatine Hospira
    Hospira, France


  • Oxaliplatine Kabi
    Fresenius, France


  • Oxaliplatine Medac
    Medac, France; Medac, Netherlands; Teva, Belgium


  • Oxaliplatine Mylan
    Mylan, France; Mylan, Netherlands


  • Oxaliplatine ratiopharm
    Ratiopharm, France


  • Oxaliplatine Sanofi
    Sanofi-Aventis, Netherlands


  • Oxaliplatine Teva
    Teva, Belgium; Teva Santé, France


  • Oxaliplatin-GRY
    Teva-Gry, Germany


  • Oxaliplatino Biocrom
    Biocrom, Argentina


  • Oxaliplatino Delta
    Delta Farma, Argentina


  • Oxaliplatino Depronal
    Vegal, Spain


  • Oxaliplatino Ebewe
    Ebewe, Italy


  • Oxaliplatino Hospira
    Hospira, Italy


  • Oxaliplatino Mayne
    Hospira, Norway; Mayne, Spain


  • Oxaliplatino Medac
    Medac, Spain


  • Oxaliplatino Milo
    Teva, Spain


  • Oxaliplatino Ratiopharm
    Ratiopharm, Spain; Ratiopharm, Italy


  • Oxaliplatino Rontag
    Rontag, Argentina


  • Oxaliplatino Sandoz
    Sandoz, Colombia


  • Oxaliplatino Servycal
    Servycal, Argentina


  • Oxaliplatino Teva
    Teva, Spain; Teva, Italy


  • Oxaliplatino Varifarma
    Varifarma, Argentina


  • Oxaliplatino
    Baxter, Chile; Biocrom, Peru; Biolatina, Chile; Kampar, Chile; Servycal, Peru


  • Oxaliplatin-ratiopharm
    Ratiopharm, Germany; Ratiopharm, Hungary


  • Oxaliprol
    Proel, Greece


  • Oxalisin
    Pharmachemie, Netherlands


  • Oxaliwin
    Winthrop, South Africa


  • Oxaltie
    Bagó, Ecuador; Bioprofarma, Argentina


  • Oxaltina
    Meditrina, Greece


  • Oxerin
    Novamed, Colombia


  • Oxitel
    Dabur, Philippines


  • Oxitropic
    Ferrer, Spain


  • Platinostyl
    Ivax, Argentina; Ivax, Peru


  • Platox
    Hospira, Poland


  • Plusplatin
    Dosa, Argentina


  • Rexta
    Kalbe, Indonesia


  • Riboxatin
    Hikma, Germany


  • Riptam
    Asofarma, Mexico


  • Sinoxal
    Merck Sharp & Dohme, Poland


  • Tecnoplat
    Tecnofarma, Peru


  • Uxalun
    Novartis, Brazil; Sandoz, Argentina


  • Winthrop Oxaliplatin
    Sanofi-Aventis, Australia


  • Xaliplat
    Richmond, Argentina; Richmond, Peru

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 24 July 2010

DBL Metronidazole Intravenous Infusion




DBL Metronidazole Intravenous Infusion may be available in the countries listed below.


Ingredient matches for DBL Metronidazole Intravenous Infusion



Metronidazole

Metronidazole is reported as an ingredient of DBL Metronidazole Intravenous Infusion in the following countries:


  • Australia

International Drug Name Search

Thursday, 22 July 2010

Ardium




Ardium may be available in the countries listed below.


Ingredient matches for Ardium



Diosmin

Diosmin is reported as an ingredient of Ardium in the following countries:


  • Indonesia

Hesperidin

Hesperidin is reported as an ingredient of Ardium in the following countries:


  • Indonesia

International Drug Name Search

dutasteride and tamsulosin


doo-TAS-ter-ide, tam-SOO-loe-sin hye-droe-KLOR-ide


Commonly used brand name(s)

In the U.S.


  • Jalyn

Available Dosage Forms:


  • Capsule

Pharmacologic Class: 5-Alpha Reductase Inhibitor


Uses For dutasteride and tamsulosin


Note: Women of childbearing potential should not use or handle dutasteride and tamsulosin. Dutasteride can cause birth defects in male fetuses.


Dutasteride and tamsulosin combination is used to treat men who have symptoms of an enlarged prostate gland, which is also known as benign prostatic hyperplasia (BPH). Benign enlargement of the prostate is a problem that can occur in men as they get older. The prostate gland is located below the bladder. When the prostate gland gets larger, certain muscles in the gland get in the way of the tube that drains urine from the bladder. This can cause problems with urinating, such as a need to urinate often, a weak stream when urinating, or a feeling of not being able to empty the bladder completely.


Dutasteride blocks the action of an enzyme called 5-alpha-reductase. This enzyme changes testosterone to another hormone that causes the prostate gland to grow. Dutasteride will cause the size of the prostate to decrease, but the effect lasts only as long as the medicine is taken. If it is stopped, the prostate begins to grow again.


Tamsulosin helps relax the muscles in the prostate gland and the opening of the bladder. This may help increase the flow of urine or decrease symptoms.


dutasteride and tamsulosin is available only with your doctor's prescription.


Before Using dutasteride and tamsulosin


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For dutasteride and tamsulosin, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to dutasteride and tamsulosin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Dutasteride and tamsulosin combination is not indicated for use in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of dutasteride and tamsulosin combination in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersXStudies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking dutasteride and tamsulosin, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using dutasteride and tamsulosin with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Atazanavir

  • Clarithromycin

  • Indinavir

  • Itraconazole

  • Ketoconazole

  • Nefazodone

  • Nelfinavir

  • Ritonavir

  • Saquinavir

  • Tadalafil

  • Telithromycin

Using dutasteride and tamsulosin with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acebutolol

  • Alprenolol

  • Atenolol

  • Betaxolol

  • Bevantolol

  • Bisoprolol

  • Bucindolol

  • Carteolol

  • Carvedilol

  • Celiprolol

  • Cimetidine

  • Ciprofloxacin

  • Dilevalol

  • Diltiazem

  • Esmolol

  • Ketoconazole

  • Labetalol

  • Levobunolol

  • Mepindolol

  • Metipranolol

  • Metoprolol

  • Nadolol

  • Nebivolol

  • Oxprenolol

  • Paroxetine

  • Penbutolol

  • Pindolol

  • Propranolol

  • Ritonavir

  • Sildenafil

  • Sotalol

  • Talinolol

  • Tertatolol

  • Timolol

  • Vardenafil

  • Verapamil

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Other Medical Problems


The presence of other medical problems may affect the use of dutasteride and tamsulosin. Make sure you tell your doctor if you have any other medical problems, especially:


  • Allergy to sulfa drugs (such as sulfamethoxazole, sulfasalazine, sulfasoxazole, Azulfidine®, Bactrim®, or Septra®)—Increased allergic reaction in patients with this condition.

  • Hypotension (low blood pressure) or

  • Postural hypotension (low blood pressure when arising), history of or

  • Priapism (painful or prolonged erection of the penis)—Use with caution. May make these conditions worse.

  • Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

Proper Use of dutasteride and tamsulosin


Take dutasteride and tamsulosin exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.


dutasteride and tamsulosin comes with a patient information insert. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.


Take the capsule approximately 30 minutes after the same meal each day. Swallow the capsule whole. Do not chew or open it.


Dosing


The dose of dutasteride and tamsulosin will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of dutasteride and tamsulosin. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (capsules):
    • For benign prostatic hyperplasia:
      • Adults—One capsule once a day.

      • Children—Use is not recommended.



Missed Dose


If you miss a dose of dutasteride and tamsulosin, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using dutasteride and tamsulosin


It is very important that your doctor check your progress at regular visits to make sure that dutasteride and tamsulosin is working properly and to check for unwanted effects.


Women and children should not use dutasteride and tamsulosin. Pregnant women or women who may become pregnant should not handle or touch the capsules. Dutasteride can be absorbed through the skin and can cause birth defects in male fetuses. If a pregnant woman does come in contact with dutasteride and tamsulosin, the affected area should be washed right away with soap and water, especially if the capsule is broken.


Because dutasteride and tamsulosin may cause some people to become dizzy or feel faint, make sure you know how you react to dutasteride and tamsulosin before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert.


Dizziness, lightheadedness, or fainting may occur after you take dutasteride and tamsulosin, especially when you get up suddenly from a lying or sitting position. Getting up slowly may help with this problem. If you feel dizzy, lie down so you do not faint. Then sit for a few moments before standing to prevent the dizziness from returning.


If you plan to have cataract surgery, tell your eye doctor (ophthalmologist) that you are taking dutasteride and tamsulosin or that you used dutasteride and tamsulosin in the previous 9 months. A serious eye problem called Intraoperative Floppy Iris Syndrome (IFIS) has occurred in some patients who were taking dutasteride and tamsulosin or who had recently taken dutasteride and tamsulosin when they had cataract surgery.


dutasteride and tamsulosin may affect the results of the prostate specific antigen (PSA) test, which may be used to detect prostate cancer. Make sure you tell all of your doctors that you are using dutasteride and tamsulosin.


dutasteride and tamsulosin will not prevent prostate cancer but may increase your risk of developing high-grade prostate cancer. Tell your doctor if you have concerns about this risk.


You should seek medical attention right away if you experience a prolonged erection while using dutasteride and tamsulosin. This is an extremely rare unwanted effect that must be treated right away to prevent permanent erectile damage (impotence).


Men who have taken dutasteride and tamsulosin should not donate blood until 6 months have passed since the last dose. Dutasteride can remain in your blood for a long time and be passed on to a pregnant woman who receives a blood transfusion.


dutasteride and tamsulosin does not usually affect normal sexual abilities for most men. You may notice that you ejaculate less fluid when you have sex.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


dutasteride and tamsulosin Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Chills

  • cold sweats

  • confusion

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

Less common
  • Chest pain

  • cough or hoarseness

  • fever

  • lower back or side pain

  • painful or difficult urination

Incidence not known
  • Blistering, flaking, or peeling of the skin

  • blurred vision

  • difficulty with breathing

  • fast, irregular, pounding, or racing heartbeat or pulse

  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

  • pain or swelling of the treated skin

  • painful or prolonged erection of the penis

  • shortness of breath

  • sweating

  • unusual tiredness or weakness

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Change or problem with discharge of semen

  • decreased interest in sexual intercourse

  • dizziness

  • enlarged and painful breasts

  • inability to have or keep an erection

  • loss in sexual ability, desire, drive, or performance

Less common
  • Back pain

  • body aches or pain

  • congestion

  • diarrhea

  • dryness or soreness of the throat

  • headache

  • increased cough

  • lack or loss of strength

  • pain or tenderness around the eyes and cheekbones

  • runny nose

  • shortness of breath or troubled breathing

  • sleepiness or unusual drowsiness

  • sleeplessness

  • sneezing

  • stuffy nose

  • tender, swollen glands in the neck

  • tightness of the chest or wheezing

  • trouble sleeping

  • trouble with swallowing

  • unable to sleep

  • voice changes

Incidence not known
  • Constipation

  • hives or welts

  • itching

  • redness of the skin

  • skin rash

  • vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: dutasteride and tamsulosin side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More dutasteride and tamsulosin resources


  • Dutasteride and tamsulosin Side Effects (in more detail)
  • Dutasteride and tamsulosin Dosage
  • Dutasteride and tamsulosin Use in Pregnancy & Breastfeeding
  • Dutasteride and tamsulosin Drug Interactions
  • Dutasteride and tamsulosin Support Group
  • 11 Reviews for Dutasteride and tamsulosin - Add your own review/rating


Compare dutasteride and tamsulosin with other medications


  • Benign Prostatic Hyperplasia

Friday, 16 July 2010

Neurodol




Neurodol may be available in the countries listed below.


Ingredient matches for Neurodol



Haloperidol

Haloperidol is reported as an ingredient of Neurodol in the following countries:


  • Tunisia

Lidocaine

Lidocaine is reported as an ingredient of Neurodol in the following countries:


  • Switzerland

International Drug Name Search

Monday, 12 July 2010

Nifecap




Nifecap may be available in the countries listed below.


Ingredient matches for Nifecap



Nifedipine

Nifedipine is reported as an ingredient of Nifecap in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, 11 July 2010

Lormetazepam Germed




Lormetazepam Germed may be available in the countries listed below.


Ingredient matches for Lormetazepam Germed



Lormetazepam

Lormetazepam is reported as an ingredient of Lormetazepam Germed in the following countries:


  • Italy

International Drug Name Search

Saturday, 10 July 2010

Tirosint




In the US, Tirosint (levothyroxine systemic) is a member of the drug class thyroid drugs and is used to treat Hashimoto's disease, Hypothyroidism - After Thyroid Removal, Myxedema Coma, Thyroid Suppression Test, TSH Suppression and Underactive Thyroid.

US matches:

  • Tirosint

Ingredient matches for Tirosint



Levothyroxine

Levothyroxine sodium salt (a derivative of Levothyroxine) is reported as an ingredient of Tirosint in the following countries:


  • Italy

  • Switzerland

International Drug Name Search

Friday, 9 July 2010

Ulcerguard




Ulcerguard may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ulcerguard



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ulcerguard in the following countries:


  • Australia

International Drug Name Search

Sunday, 4 July 2010

Herplex




In the US, Herplex (idoxuridine ophthalmic) is a member of the drug class ophthalmic anti-infectives.

US matches:

  • Herplex

Ingredient matches for Herplex



Acyclovir

Aciclovir is reported as an ingredient of Herplex in the following countries:


  • Croatia (Hrvatska)

Idoxuridine

Idoxuridine is reported as an ingredient of Herplex in the following countries:


  • Bangladesh

  • Bosnia & Herzegowina

  • United States

International Drug Name Search